Mozistobart zoratolimod
Mozistobart zoratolimod is an antibody-oligonucleotide conjugate (AOC) composed of a humanized monoclonal antibody (HY-P990930 Mozistobart) targe ting CD22 linked to a TLR9 agonist. It is used for the study of cancer immunotherapy.
Product Specifications
CAS Number
[2852752-99-7]
Product Name Alternative
TAC-001
UNSPSC
12352203
Target
Antibody-Oligonucleotide Conjugates (AOCs) ; CD22; Toll-like Receptor (TLR)
Related Pathways
Antibody-drug Conjugate/ADC Related; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[Mozistobartzoratolimod]
References & Citations
[1]WHO Drug Information, Vol. 37, No. 4, 2023
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported
Isoform
TLR9
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
